lysylvaline (Lys-Val)

Also Known As:
Lys-Val; lysyl-valine
Networked: 7 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results


1. Pillai, M R A: 1 article (08/2004)
2. Venkatesh, Meera: 1 article (08/2004)
3. Chakraborty, Sudipta: 1 article (08/2004)
4. Srivastava, Sudha: 1 article (08/2004)
5. Das, Tapas: 1 article (08/2004)
6. Samuel, Grace: 1 article (08/2004)
7. Korde, Aruna: 1 article (08/2004)
8. Banerjee, Sharmila: 1 article (08/2004)
9. Cassoni, P: 1 article (04/2002)
10. Marrocco, T: 1 article (04/2002)

Related Diseases

1. Hemorrhage
2. Neoplasms (Cancer)
08/01/2004 - "Lanreotide, [beta-naphthyl-Ala-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2] a disulfide-linked cyclic octapeptide and a somatostatin analog, reported to bind with a wide variety of tumors expressing somatostatin receptors, was conjugated with DOTA. "
05/01/1997 - "Rhenium-188-labeled hydroxyethylidenediphosphonate (HEDP) and Re-188-dimercaptosuccinic acid (DMSA) are being applied for palliative treatment of pain associated with skeletal metastases, and the Re-188-RC-160 somatostatin analogue [cyclic NH2-(D)-Phe-Cys-Try-(D)-Trp-Lys-Val-Cys-Trp-NH2] for somatostatin-receptor-positive tumors. "
11/05/1982 - "The primary structure of the tumor-derived peptide is H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala- Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly -Ala-Arg-Ala-Arg-Leu-NH2. "
01/01/1992 - "The effects of treatment with a bombesin receptor antagonist [D-Tpi6, Leu13 psi (CH2NH) Leu14]BN(6-14)(RC-3095) and the combination of an agonist of luteinizing hormone-releasing hormone [D-Trp6]-LH-RH and somatostatin analog D-Phe-Cys-Tyr-D-Trp-Lys-Val- Cys-Trp-NH2 (RC-160) were studied in nude mice bearing xenografts of the hormone-dependent human prostate tumor PC-82. "
07/01/1984 - "Amino acid sequence determination using a gas-phase sequencer and reverse-phase liquid chromatography of the native peptide and its synthetic replicates showed its primary structure to be as follows: H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln -Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser -Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2, which is identical to that of the GRF recently isolated and characterized from a human pancreatic tumor that had caused acromegaly. "
3. Thyroid Neoplasms (Thyroid Cancer)
4. Pain (Aches)
5. Neoplasm Metastasis (Metastasis)

Related Drugs and Biologics

1. Somatostatin (Somatotropin Release-Inhibiting Factor)
2. Adrenocorticotropic Hormone (ACTH)
3. alanyltyrosine
4. Somatostatin Receptors (Somatostatin Receptor)
5. glutaminyl-glycine (Gln-Gly)
6. arginyllysine
7. cysteinyltyrosine
8. leucylleucine (Leu-Leu)
9. alanylaspartic acid
10. kyotorphin (Tyr-Arg)

Related Therapies and Procedures

1. Intraventricular Infusions
2. Heterologous Transplantation (Xenotransplantation)
3. Palliative Care (Palliative Medicine)